SCHEMBL6538737

SCHEMBL6538737

CC(C)n1nc(C2=C(c3ccccc3)NC3=C(C2)C(=O)OC3)ccc1=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BMPR1A P36894 3/20 0.38
ACVRL1 P37023 3/20 0.38
ACVR1 Q04771 3/20 0.38
BMPR1B O00238 2/20 0.38
TGFBR1 P36897 2/20 0.38
HSD11B1 P28845 1/20 0.37
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.32
KDM4E B2RXH2 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
HRH3 Q9Y5N1 2/20 0.32
KMT2A Q03164 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30
SLC5A1 P13866 1/20 0.30
HSD17B10 Q99714 1/20 0.30
KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539323 0.78 DDB1 (0.40) BMPR1AACVRL1ACVR1BMPR1BTGFBR1
SCHEMBL6538762 0.73 TP53 (0.38) HSD11B1TP53POLBKDM4EKMT2A
SCHEMBL6539242 0.68 HTR2A (0.39) BMPR1AACVRL1ACVR1BMPR1BTGFBR1
SCHEMBL6539735 0.66 HTR2A (0.41) BMPR1AACVRL1ACVR1BMPR1BTGFBR1
SCHEMBL6538291 0.65 BRD4 (0.39) POLBDDB1CRBNKMT2AKDR
SCHEMBL5150930 0.65 TP53 (0.40) BMPR1AACVRL1ACVR1BMPR1BTGFBR1
SCHEMBL5149029 0.64 TP53 (0.44) BMPR1AACVRL1ACVR1BMPR1BTGFBR1
SCHEMBL6539443 0.64 CRBN (0.34) BMPR1AACVRL1ACVR1BMPR1BTGFBR1
SCHEMBL6538758 0.63 PDE10A (0.38) BMPR1AACVRL1ACVR1BMPR1BTGFBR1
SCHEMBL5147958 0.63 ADORA2A (0.39) BMPR1AACVRL1ACVR1BMPR1BTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof ADORA1, ADORA2A, P2RX5 BMPR1A 2100/4885ACVRL1 1836/4885ACVR1 1613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.